Al-sharefi, Ahmed <br/><br/>
Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.  [electronic resource] 

 -  BMJ case reports  Sep 2015 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1757-790X 
<br/><br/><label>Standard No.: </label>10.1136/bcr-2015-210727  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antimanic Agents--administration & dosage<br/>Brain Diseases--chemically induced<br/>Cardiomyopathies--chemically induced<br/>Carnitine--blood<br/>Female<br/>Humans<br/>Hyperammonemia--chemically induced<br/>Muscle Weakness--chemically induced<br/>Muscular Diseases--chemically induced<br/>Psychotic Disorders--drug therapy<br/>Treatment Outcome<br/>Valproic Acid--administration & dosage